– Interview with James Greenwood, president and CEO of the Biotechnology Industry Organization

Previous articleTeva Ponies Up €3.625B for Ratiopharm
Next articleJDRF, Pfizer, Hadassah Medical, and The Hebrew University Forge Type 1 Diabetes Pact